SPENCER VIDULICH – Trademark Portfolio
Entity Type: 01
SPENCER VIDULICH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include THE EYE CARE YOU NEED and OUR MISSION IS YOUR GOOD VISION. The owner is based in CHICAGO, IL.
4411 N. WINCHESTER
CHICAGO, IL 60640
Showing of trademarks Trademarks
Trademark Classifications
SPENCER VIDULICH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does SPENCER VIDULICH have?
SPENCER VIDULICH has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does SPENCER VIDULICH file in?
SPENCER VIDULICH files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are SPENCER VIDULICH's most well-known trademarks?
SPENCER VIDULICH's registered trademark portfolio includes well-known marks such as THE EYE CARE YOU NEED and OUR MISSION IS YOUR GOOD VISION. These are among 2 currently registered trademarks in the portfolio.
What is SPENCER VIDULICH's trademark registration success rate?
SPENCER VIDULICH has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.